CLOSE

Benchmark Investments

Nippon India Pharma Fund(G)

very highequitypharma & health care
517.97 -5.90(-1.13%) NAV as on 18 Sep 2024
4.11 % 1 M
46.95 % 1 Y
18.14 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

1.80

As on 31 Aug, 2024
Age :

20 yrs 3 m

Since 05 06 ,2004
Exit Load :

1%

AUM :

8,647.95 Crs

Portfolio Price To Book Value :

8.76

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Sailesh Raj Bhan

Launch Date :

05-Jun-04

Scheme Benchmark :

NA

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Aug 31 ,2024
Others 2.60 %
Equity 97.40 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.81 %
Lupin Ltd.8.30 %
Divi's Laboratories Ltd.7.96 %
Cipla Ltd.5.93 %
Dr. Reddy's Laboratories Ltd.5.69 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs79.24
Hospital & Healthcare Services16.10
Business Support1.13
Trading0.93
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)143.39250.18290.14270.59428.87
Net Assets(Rs Crores) (as on 31-Mar-2024) 2189.84 4260.99 4931.89 4304.46 7125.28
Scheme Returns(%)(Absolute)-5.8377.3614.83-6.8558.24
B'mark Returns(%)(Absolute)NANANANANA
Category Rank14/7532/7543/7565/7617/90

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-20254.01NANANA
2023-202417.1011.2311.589.06
2022-2023-10.128.200.15-4.25
2021-202222.060.731.97-7.50
2020-202131.5919.5012.24-1.15

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity517.97-5.90(-1.13%)NAV As on 18 Sep, 202405-Jun-2004Inception Date8,647.95AUM In Cr.46.95%1Y18.14%3Y29.59%5Y21.46%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity38.72-0.36(-0.92%)NAV As on 18 Sep, 202413-Jul-2018Inception Date4,807.86AUM In Cr.59.15%1Y21.91%3Y32.10%5Y24.45%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity415.89-3.93(-0.94%)NAV As on 18 Sep, 202414-Jul-1999Inception Date3,202.66AUM In Cr.47.92%1Y20.76%3Y30.01%5Y16.70%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.07-0.33(-1.04%)NAV As on 18 Sep, 202428-Dec-2015Inception Date1,183.18AUM In Cr.53.11%1Y19.67%3Y28.30%5Y13.86%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity40.40-0.20(-0.50%)NAV As on 18 Sep, 202430-Nov-2018Inception Date2,934.17AUM In Cr.53.25%1Y19.29%3Y31.96%5Y27.19%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd